Medical expenses for chronic disease treatment in South Korea has increased from ₩4.8 trillion to ₩17.4 trillion for the last 10 years. It has increased by more than 3.6 times, and has occupied 36.3% of totala medical cost.

Considering the fastest entry into the elderly society by the year 2018, aggravation of the death and disease  structure by chronic disease and social burden is inevitable. To respond to the structural change towards chronic diseases that will prevail, advanced prevention by strengthening the clinical preventive service is necessary.

Thus, actuarial budget for clinical preventive services that is of high necessity and is verified to be effective need to be provided. Although there have been some proposal of recommendation from associated organizations, there has not been any systematic evidence established for educational counseling, preventative medication, and treatment services. In other words, it is necessary to organize clinical preventive service based on evidence, and to review the priority for clinical preventive service. 

In this study, we planned to setup the concept and scope for the clinical preventive service, and understand the priority for the insurance payment. Such study was done based on recommendation proposals, grades, and payment status of major countries through paper review and investigation with related organizations. With the above basis, delphi survey was conducted upon professionals for the insurance priority, evaluation index, and fields of clinical preventive service. Based on the survey results, systematic review was done for clinical effectiveness and cost effectiveness of each clinical preventive service.